CAS: 1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS:1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. …
Formula:
C27H35F3N4O3S
Purezza:
Min. 95%
Peso molecolare:
552.65 g/mol
Ref: 3D-CXC70604
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Maggio 2024
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrrolo[3,4-b]pyridine-3-carboxamide
Prodotto ControllatoCAS:1802706-04-2
Formula:
C27H35F3N4O3S
Colore e forma:
White to Off-White Solid
Peso molecolare:
552.652
Ref: TR-E890955
75mg | 22.540,00 € |
Consegna stimata in Stati Uniti, il Giovedì 20 Giugno 2024
Vimirogant
CAS:1802706-04-2
Vimirogant is a RORγ inhibitor (Ki: <100 nM).
Formula:
C27H35F3N4O3S
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
552.65
Ref: TM-T16787
25mg | 2.106,00 € | |
50mg | 2.785,00 € | |
100mg | 3.739,00 € |
Consegna stimata in Stati Uniti, il Giovedì 08 Agosto 2024